Henry Schein (HSIC) Competitors

Chemed (NYSE:CHE) and Henry Schein (NASDAQ:HSIC) are both mid-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, profitability, valuation, community ranking, analyst recommendations, dividends, earnings, media sentiment and risk.

Which has more volatility & risk, CHE or HSIC?

Chemed has a beta of 0.42, indicating that its share price is 58% less volatile than the S&P 500. Comparatively, Henry Schein has a beta of 0.87, indicating that its share price is 13% less volatile than the S&P 500.

Do insiders and institutionals have more ownership in CHE or HSIC?

95.9% of Chemed shares are owned by institutional investors. Comparatively, 96.6% of Henry Schein shares are owned by institutional investors. 3.3% of Chemed shares are owned by insiders. Comparatively, 1.1% of Henry Schein shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Does the media refer more to CHE or HSIC?

In the previous week, Chemed had 1 more articles in the media than Henry Schein. MarketBeat recorded 15 mentions for Chemed and 14 mentions for Henry Schein. Chemed's average media sentiment score of 0.82 beat Henry Schein's score of 0.25 indicating that Henry Schein is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Chemed	2 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	3 Negative mention(s)	1 Very Negative mention(s)	Neutral
Henry Schein	5 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community believe in CHE or HSIC?

Henry Schein received 38 more outperform votes than Chemed when rated by MarketBeat users. However, 63.44% of users gave Chemed an outperform vote while only 51.55% of users gave Henry Schein an outperform vote.

Company	Underperform	Outperform
Chemed	Outperform Votes 328 63.44%	Underperform Votes 189 36.56%
Henry Schein	Outperform Votes 366 51.55%	Underperform Votes 344 48.45%

Which has higher valuation and earnings, CHE or HSIC?

Henry Schein has higher revenue and earnings than Chemed. Henry Schein is trading at a lower price-to-earnings ratio than Chemed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chemed	$2.26B	3.84	$272.51M	$17.92	32.12
Henry Schein	$12.34B	0.76	$416M	$3.15	23.10

Do analysts rate CHE or HSIC?

Chemed presently has a consensus price target of $681.00, indicating a potential upside of 17.85%. Henry Schein has a consensus price target of $81.09, indicating a potential upside of 11.63%. Given Henry Schein's stronger consensus rating and higher possible upside, equities analysts plainly believe Chemed is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chemed	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Henry Schein	1 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.36

Is CHE or HSIC more profitable?

Chemed has a net margin of 12.03% compared to Chemed's net margin of 3.37%. Henry Schein's return on equity of 32.29% beat Chemed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chemed	12.03%	32.29%	20.74%
Henry Schein	3.37%	14.03%	6.22%

Summary

Chemed beats Henry Schein on 11 of the 18 factors compared between the two stocks.